Asthma in women of color and or low income
•Télécharger en tant que PPT, PDF•
0 j'aime•216 vues
Asthma in women of color and/or low income Noreen M. Clark University of Michigan Center for Managing Chronic Disease
![Asthma in Women of Color and/or Low Income Noreen M. Clark, PhD, Molly Gong, MD, Sijian Wang, MS, Melissa Valerio, MPH, William Bria, MD, Xihong Lin, PhD, Timothy Johnson, MD University of Michigan - School of Public Health RATIONALE : The purpose of this study was to compare management problems of women with asthma of different races and socioeconomic status. METHODS: Telephone interview data were collected from 590 participants attending asthma clinics within the University of Michigan Health System. 37% (n=160) were women of color and/or from low income families (less than $20,000). Poisson and Logistic regression models were conducted to ascertain group differences. RESULTS : Women of color were 4 times more likely to be at the low income level than white women (OR=4.0, p=.0001). Women of color and/or from low income families were 1.6 times more likely to have persistent disease (OR=1.6, p=.016), 4.9 hospitalizations (RR=4.9, p=.0001), 1.8 ED visits (RR=1.8, p=.002), 1.3 unscheduled urgent office visits (RR=1.3, p=.0007), and 1.5 follow-up visits for an asthma episode (RR=1.5, p=.006) compared to non-minority women and/or those of higher income. They used less inhaled corticosteroid medicine (OR=0.7, p=.025) and less long-acting inhaled bronchodilators (OR=0.6, p=.02). Although not statistically significant, they also used more oral steroids (OR=1.5, p=.1) and more home remedies (OR=1.7, p=.3). They also were more likely to have lower levels of self-esteem (p=.05), asthma knowledge (p=.01), and asthma-related quality of life (p=.02). Significantly more women of color and/or from low income families reported that they had never visited a specialist for asthma (OR=.06, p=.006) and were not satisfied with the medical care they received (OR=0.3, p=.05). CONCLUSION : Women of color and/or from low income families confront more asthma management difficulties and bear greater burden of the disease. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ABSTRACT BACKGROUND & METHODS FINDINGS CONCLUSIONS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],OR=1.6 .016 45% 56% Persistent Asthma (%) <.05 3.1 (SD=4.1) 4.3 (SD=4.9) Yearly Average nights of nighttime symptoms <.05 4.6 (SD=5.5) 6.1 (SD=5.9) Yearly average days of daytime symptoms p-value White & not low income (N=433) Minority and/ or low income (N=156) .0055 .0007 .0019 <.0001 p-value 1.46 1.34 1.84 4.90 Relative Risk 0.14 0.09 0.20 0.30 S.E. 0.38 0.29 0.61 1.59 Estimation Follow-up visits Unscheduled Visits ED visits Hospital admission 1 = Minority & low income 0 = White & not low income 0..3 1.66 3% 5% Home remedies .019 0.64 55% 44% Long-acting inhaled bronchodilators .025 0.65 62% 52% Inhaled corticosteroids .042 0.68 63% 51% Inhaled anti-inflammatory medications p-value Odds Ratio White & not low income (N=422) Minority & low income (N=151) 0.049 0.05 0.0219 p-value -0.09 -0.1407 0.1779 Estimation Self-esteem Asthma Knowledge Quality of life 1 = Minority & low income 0 = White & not low income](https://image.slidesharecdn.com/asthmainwomenofcolorandorlowincome-100513153751-phpapp02/85/Asthma-in-women-of-color-and-or-low-income-1-320.jpg)
Asthma in women of color and/or low income Noreen M. Clark University of Michigan Center for Managing Chronic Disease
